Finasteride (Propecia / Proscar)
Prescription hair loss and prostate drug that lowers levels of the hormone DHT in the scalp by about 70%.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is Finasteride (Propecia / Proscar)?
Finasteride is a prescription medicine, sold under the brand names Propecia and Proscar. It was originally approved for an enlarged prostate and later also for male pattern hair loss. Steroid-using bodybuilders also use it against the hair loss that gets worse alongside steroid use.
It blocks the enzyme that turns testosterone into DHT (dihydrotestosterone, a strong male hormone), lowering DHT in the scalp by about 70%. Hair loss slows and some hair may grow back, but this takes months. Sexual side effects (lower sex drive, erection and ejaculation problems) are common; they usually go away after stopping, but rare, disputed cases of lasting complaints have been described. The official prescribing information also warns about mood problems (depression, anxiety and, rarely, suicidal thoughts). It must not be used in pregnancy, because it can cause abnormal development of a male baby's genitals. It is not on the anti-doping list.
Mechanism
Blocks the second type of 5α-reductase; about 70% less DHT in the scalp
Half-life
~6 h parent, pharmacodynamic effect 24+ h enzyme inhibition
Onset
DHT reduction measurable 24 h, hair stabilization 3-6 months
Legal status
FDA + EMA Rx, HU + PL approved, WADA allowed (not 5AR-banned)
No anecdote collected yet.
Data console
Lab data
Van Neste D . Viable terminal scalp hair follicles constitute a necessary and sufficient biological end-organ that conditions clinical efficacy of finasteride 1mg.. Skin Res Technol.
Jędrzejczyk P, Ząbkowski T, Ratajski J . Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study.. J Clin Med.
Dhurat R, Sharma A, Rudnicka L, Kanti V, Vañó-Galván S, Pirmez R, Sinclair R, Doolan B, Tosti A . 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.. Dermatol Ther.
Kaufman KD, Rotonda J, Shah AK, Meehan AG. . Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2008;18(4):400-406..
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Sexual dysfunction: reduced libido, erectile dysfunction, decreased ejaculate volume (about 2–8%, dose-dependent, most common adverse effect).
- Post-finasteride syndrome (PFS): sexual, mood and cognitive symptoms persisting even after discontinuation (about 1–2%, neurosteroid-mediated, controversial but growing evidence).
- Mood disturbance: depression, anxiety, anhedonia, rarely suicidal ideation (FDA label warning).
- Gynecomastia and breast tenderness: due to the testosterone→estrogen shift from DHT blockade (rare but documented; any new breast lump must be evaluated to rule out breast cancer).
- Roughly 50% reduction in PSA level: can mask prostate cancer screening, the PSA value requires correction in clinical interpretation.
- Initial shedding (telogen effluvium): a paradoxical transient increase in hair loss may occur in the first 4–8 weeks of therapy.
- Rare cholestasis / liver enzyme elevation and hypersensitivity reactions (rash, pruritus, angioedema) reported in isolated cases.
Contraindications · 7
- Pregnancy and pregnant (or potentially pregnant) partner: Pregnancy Category X – DHT suppression can cause malformation of the fetal male external genitalia. A pregnant woman must NOT handle the tablets (especially broken/crushed ones).
- Women (of childbearing potential) and children: not indicated; teratogenic risk and no proven benefit.
- History of depression or other mood disorder: relative contraindication due to increased risk of mood side effects and PFS.
- Known hypersensitivity to finasteride or other 5α-reductase inhibitors (e.g. dutasteride).
- Adolescents (<18 years): 5AR blockade during development is not indicated.
- Severe hepatic impairment: finasteride is metabolized in the liver (CYP3A4), caution / monitoring is required with reduced function.
- Family history of androgen insensitivity syndrome (AIS) or AR mutation: further reduction of androgen signaling should be avoided.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Viable terminal scalp hair follicles constitute a necessary and sufficient biological end-organ that conditions clinical efficacy of finasteride 1mg.
Van Neste D
Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study.
Jędrzejczyk P, Ząbkowski T, Ratajski J
5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.
Dhurat R, Sharma A, Rudnicka L, Kanti V, Vañó-Galván S, Pirmez R, Sinclair R, Doolan B, Tosti A
Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia
Kaufman KD, Rotonda J, Shah AK, Meehan AG.
Telegram
Have a question about Finasteride (Propecia / Proscar)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.

